Meaghan Gray represents hospital systems and other healthcare providers in managed care reimbursement disputes. She works closely with members of the firm’s managed care litigation team to develop effective and strategic solutions tailored to clients’ operational and financial goals. Understanding that the healthcare industry is constantly undergoing growth and change, she advises clients on the latest legal and business developments and helps them resolve disputes through negotiation, arbitration and litigation.

Meaghan regularly represents healthcare providers in both in-network and out-of-network reimbursement disputes, including matters involving underpayments, line-item denials and payor policy challenges. She regularly handles reimbursement disputes involving ERISA-governed plans and advises clients on ERISA-related issues, including preemption defenses. Meaghan is well-versed in state and federal surprise billing laws, including the No Surprises Act (NSA).

She advises healthcare providers on NSA compliance and various issues stemming from the NSA’s independent dispute resolution (IDR) process. She also represents healthcare providers in NSA enforcement matters that arise when payors fail to timely or fully pay IDR awards.

Education

  • Belmont University College of Law (J.D., cum laude, Dean’s List, 2021)
    • Sewanee: The University of the South (B.A., summa cum laude, 2017)
      • Psychology, Phi Beta Kappa member, Order of the Gown member  

    Bar Admission

    • Tennessee

    Court Admissions

    • U.S. Court of Appeals, Sixth Circuit
    • U.S. District Court, Western District of Tennessee

    Professional Affiliations

    • Tennessee Bar Association 
    • American Health Law Association 

    Recognition

    • Named one of Best Lawyers: Ones to Watch® in America in Health Care Law, 2025-2026
    • Belmont Health Law Certificate
    • Article and Notes Editor for the Belmont Law Review
    • Belmont Health Law Research Assistant
    • Best Performance Award in Legal Information & Communication I
    • Best Performance Award in Legal Information & Communication II
    • CALI Excellence for the Future Award for Legal Research & Writing

    Community

    • Young Leaders Council Nashville
    • Harry Phillips American Inn of Court
      • Associate Member
    Publications
    All Publications
    Reimbursement End-of-Year Highlights
    Polsinelli is pleased to share the Reimbursement Quarterly Newsletter. This publication contains articles and insight into issues that affect Reimbursement. In this issue: Select Highlights from CY 24 Medicare Physician Fee Schedule Final Rule IPPS Highlights CY 2024 OPPS Final Rule Summary for RI Year-End Review 2023 OIG Releases New General Compliance Program Guidance Highlights from the Final Home Health and Hospice Payment Rules Key Updates to Telehealth Reimbursement for 2024 A Busy Year for 340B Programs and Covered Entities SNF 2024 Forecast Significant Policy Updates in Behavioral Health CMS Finalizes Changes to Medicare Provider Enrollment Rules Four Major Issues Medicaid Providers Need to Know for Fiscal Year 2024 2023 CMS Innovation Center Updates Recent Federal Price Transparency Requirements for Hospitals and Plans Medicare Advantage Reimbursement Trends to Watch Including CMS's Proposed Rule Key Takeaways for
    Read More
    CMS Halts No Surprises Act IDR Process After Federal Court Sides with Providers on Claim Batching and Increased Fees
    Key Takeaways On Thursday, August 3, 2023, a federal court issued a memorandum and order in Texas Medical Association, et al. v. United States Department of Health and Human Services, Case No. 6:23-cv-59-JDK (“TMA IV”), tossing the sharp fee increase to participate in the independent dispute resolution (“IDR”) process under the No Surprises Act (“NSA”) and vacating a regulation that significantly limited the ability to batch multiple items and services into a single dispute. This is the third time in approximately 18 months that aspects of the NSA’s rules and regulations have been vacated as unlawful. In response, the Biden administration has suspended the IDR process pending further guidance. Overview The NSA protects consumers from unexpected medical bills for certain out-of-network health care services and requires providers
    Read More